Production (Stage)
CervoMed Inc.
CRVO
$7.26
$0.141.97%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 35.24M | 38.92M | 46.66M | 45.09M | 6.37M |
Total Receivables | 1.63M | 2.25M | 264.10K | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.70M | 1.91M | 1.89M | 2.24M | 1.35M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | 247.70K |
Total Current Assets | 38.58M | 43.08M | 48.81M | 47.33M | 7.97M |
|
|||||
Total Current Assets | 38.58M | 43.08M | 48.81M | 47.33M | 7.97M |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | 73.90K | 56.20K | 31.90K |
Total Assets | 38.58M | 43.08M | 48.88M | 53.19M | 8.00M |
|
|||||
Total Accounts Payable | 1.86M | 1.51M | 1.08M | 725.90K | 679.70K |
Total Accrued Expenses | 1.98M | 2.25M | 2.07M | 969.60K | 1.35M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 102.50K | 115.90K | 98.70K | 1.52M | 636.30K |
Total Other Current Liabilities | 102.50K | 115.90K | 98.70K | 1.52M | 636.30K |
Total Current Liabilities | 3.94M | 3.88M | 3.25M | 3.21M | 2.66M |
|
|||||
Total Current Liabilities | 3.94M | 3.88M | 3.25M | 3.21M | 2.66M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 3.94M | 3.88M | 3.25M | 3.21M | 2.66M |
|
|||||
Common Stock & APIC | 110.24M | 109.88M | 109.54M | 109.27M | 62.29M |
Retained Earnings | -75.63M | -70.73M | -64.03M | -59.29M | -56.96M |
Treasury Stock & Other | 21.20K | 56.20K | 123.20K | -- | -- |
Total Common Equity | 34.63M | 39.20M | 45.64M | 49.98M | 5.34M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 34.63M | 39.20M | 45.64M | 49.98M | 5.34M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 34.63M | 39.20M | 45.64M | 49.98M | 5.34M |
|